ro13-9904 and Prostatic-Hyperplasia

We studied 599 evaluable patients with benign prostatic hypertrophy at 7 urological units. Before transurethral prostatectomy the patients were randomized into 3 groups: group 1--197 patients given single-dose ceftriaxone (2 gm.), group 2--203 patients given 160/800 mg. trimethoprimsulfamethoxazole and group 3--199 controls given no antimicrobial prophylaxis. Patients with a preoperative indwelling catheter, positive urine culture, signs of active infection or preoperative antibiotic treatment were excluded. Postoperative infectious complications were demonstrated in 15 of 197 (7.6%), 25 of 203 (12.3%) and 43 of 199 (21.6%) patients in the study groups, respectively. The difference in infectious complications between groups 1 and 3 was statistically highly significant (p < 0.01) and between groups 2 and 3 it was significant (p < 0.05). Single-dose antibiotic prophylaxis proved to be useful in the prevention of serious infectious complications after transurethral prostatectomy.

Topics: Aged; Aged, 80 and over; Bacterial Infections; Ceftriaxone; Humans; Male; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Prostatectomy; Prostatic Hyperplasia; Trimethoprim, Sulfamethoxazole Drug Combination

Topics: Abscess; Administration, Oral; Aged; Anti-Bacterial Agents; Ceftriaxone; Diabetes Mellitus, Type 2; Diagnosis, Differential; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Prostatic Diseases; Prostatic Hyperplasia; Tomography, X-Ray Computed

A total of 46 patients aged 59-84 who underwent transurethral resection of the prostate gland received 2 g of ceftriaxone intravenously at different points in time, ranging from 30 min to 74 h before the operation. The antibiotic concentration was determined in the serum as well as in the prostate adenoma tissue using microbiological methods after treating the tissue in a stomacher. 30 min after application, tissue concentrations were between 12.9 and 73.7 micrograms/g, and after 4 h still between 1.0 and 50.0 micrograms/g. Even after 48 h levels between 0.6 and 5.6 micrograms/g were found. Therefore ceftriaxone proved not only to have a long serum half-life as compared to other comparable cephalosporins, but also prolonged tissue concentrations, which justifies a single preoperative dose before transurethral resection of the prostate gland, as established by the clinical results described.

Topics: Aged; Biological Assay; Cefotaxime; Ceftriaxone; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Prostatic Hyperplasia